For an updated comparison, the cagrilintide vs retatrutide comparison covers the head-to-head data
These results are promising, but more research is also needed to find out why GLP-1s may reduce death from all causes in this group
8 Saxenda [prescribing information]
18 Hypercalcemia Acute pancreatitis due to hypercalcemia is uncommon, but it can be life-threatening
It should also be noted that, from a methodological perspective, the model used (Cox with stratification by cardiovascular risk class of the trials, i.e., SURPASS-4: high risk, and all others: low risk) requires various assumptions, including the homogeneity of the relative effect of tirzepatide treatment on MACE regardless of the baseline cardiovascular risk level of the patients
What Some Of The Evidence Shows So Far A 2025 brief case series using modelling examined less frequent dosing of GLP-1s for weight maintenance